Researchers from KU Leuven, the University of California Davis Medical Center, the University of Cologne, and over 20 ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

The reemergence of the New World screwworm, which poses significant health risks for livestock, has prompted the Department ...